Wednesday, February 10, 2021 6:10:15 AM
Voyager Announces Private Placement
News provided by
Voyager Digital Ltd.
Feb 09, 2021, 09:22 ET
Share this article
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES./
NEW YORK, Feb. 9, 2021 /CNW/ - Voyager Digital Ltd. (CSE: VYGR) (the "Company" or "Voyager") is pleased to announce that it has increased the size of the previously announced best efforts private placement with Stifel GMP where the Company shall be offering for sale common shares of the Company (the "Shares") for aggregate proceeds of approximately US$100,000,000 at a price of US$13.10 per Share (equivalent C$17.00 per share) (the "Treasury Offering").
The net proceeds from the Offering will be used for general corporate purposes.
Contemporaneous with the Treasury Offering certain shareholders of the Company intend to sell approximately up to US$44,000,000 in Shares (the "Secondary Offering") at the same price as Shares sold in the Treasury Offering, of this amount approximately forty percent is being sold by an insider of the Company.
The Treasury Offering is scheduled to close on or about February 12, 2021 and is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and other approvals including the approval of the Canadian Securities Exchange.
This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws and may not be offered or sold within the United States or to or for the account or benefit of a U.S. person (as defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM